Kevin Caliendo
Stock Analyst at UBS
(4.42)
# 266
Out of 4,902 analysts
184
Total ratings
69.32%
Success rate
11.42%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Buy | $284 → $282 | $243.29 | +15.91% | 3 | Jul 18, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $400 → $385 | $282.93 | +36.08% | 12 | Jun 25, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $8.5 | $4.25 | +100.00% | 4 | May 27, 2025 | |
| ZIMV ZimVie | Maintains: Neutral | $16 → $10 | $8.42 | +18.76% | 1 | May 15, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $6 → $5.25 | $4.72 | +11.23% | 4 | May 13, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $27 → $25 | $15.65 | +59.80% | 10 | May 9, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $15 | $9.50 | +57.89% | 3 | May 9, 2025 | |
| AMWL American Well | Maintains: Neutral | $12 → $9 | $8.05 | +11.80% | 3 | May 8, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $21 → $18 | $19.45 | -7.43% | 3 | May 5, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $16 → $17 | $12.48 | +36.22% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $170 | $159.85 | +6.35% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $71 | $62.10 | +14.33% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $708 → $805 | $711.26 | +13.18% | 14 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $294.19 | +13.87% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $188.65 | +13.97% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $83 → $80 | $69.15 | +15.69% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $13 | $7.86 | +65.39% | 5 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $330 → $305 | $188.83 | +61.52% | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $296.00 | +31.76% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $170 | $167.00 | +1.80% | 13 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.50 | -13.01% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $218.30 | +14.52% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $28.15 | +180.64% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $20.98 | +23.93% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $282.32 | +103.67% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $163.91 | +9.82% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.99 | +801.13% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $16.00 | -31.25% | 4 | May 4, 2021 |
Labcorp Holdings
Jul 18, 2025
Maintains: Buy
Price Target: $284 → $282
Current: $243.29
Upside: +15.91%
UnitedHealth Group
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $282.93
Upside: +36.08%
LifeStance Health Group
May 27, 2025
Upgrades: Buy
Price Target: $8.5
Current: $4.25
Upside: +100.00%
ZimVie
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $8.42
Upside: +18.76%
GoodRx Holdings
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $4.72
Upside: +11.23%
DENTSPLY SIRONA
May 9, 2025
Maintains: Buy
Price Target: $27 → $25
Current: $15.65
Upside: +59.80%
Evolent Health
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $9.50
Upside: +57.89%
American Well
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $8.05
Upside: +11.80%
Envista Holdings
May 5, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $19.45
Upside: -7.43%
Alignment Healthcare
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $12.48
Upside: +36.22%
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $159.85
Upside: +6.35%
May 2, 2025
Maintains: Neutral
Price Target: $67 → $71
Current: $62.10
Upside: +14.33%
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $711.26
Upside: +13.18%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $294.19
Upside: +13.87%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $188.65
Upside: +13.97%
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $69.15
Upside: +15.69%
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $7.86
Upside: +65.39%
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $188.83
Upside: +61.52%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $296.00
Upside: +31.76%
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $167.00
Upside: +1.80%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.50
Upside: -13.01%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $218.30
Upside: +14.52%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $28.15
Upside: +180.64%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $20.98
Upside: +23.93%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $282.32
Upside: +103.67%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $163.91
Upside: +9.82%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.99
Upside: +801.13%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $16.00
Upside: -31.25%